- Alle
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01:30 | Immuno-responsive cancer biotech Eikon Therapeutics files for an estimated $300 million IPO | 2 | Renaissance Capital | ||
| 00:30 | US IPO Week Ahead: Markets set for a quiet week after year's first sizable IPO | 1 | Renaissance Capital | ||
| 00:30 | US IPO Weekly Recap: Aktis Oncology leads as first sizable 2026 IPO | 1 | Renaissance Capital | ||
| 00:30 | Hair loss biotech Veradermics files for a $100 million IPO | 3 | Renaissance Capital | ||
| Fr | Bleichroeder Acquisition Corp. II nimmt bei Börsengang 287,5 Millionen US-Dollar ein | 1 | Investing.com Deutsch | ||
| Fr | Bleichroeder Acquisition Corp. II raises $287.5 million in IPO | 1 | Investing.com | ||
| Fr | First Student mandatiert Goldman Sachs, Morgan Stanley und RBC für Börsengang - Bloomberg | 4 | Investing.com Deutsch | ||
| Fr | Chinese AI Company MiniMax Sees Share Price Double on Day of IPO | 5 | PYMNTS.com | ||
| Fr | Budget furniture retailer Bob's Discount Furniture files for an estimated $400 million IPO | 1 | Renaissance Capital | ||
| Fr | Brazilian mineral exploration company Atlas Critical Minerals prices upsized US IPO at $8, below the range | 2 | Renaissance Capital | ||
| Fr | Aktis Has First Biotech IPO of 2026, Raising $318M to Expand the Reach of Radiopharmaceuticals | 1 | MedCity News | ||
| Fr | Bain tests IPO window with Bob's Discount Furniture filing | 3 | Private Equity Insights | ||
| Fr | Bain Capital-backed Bob's Discount Furniture files for US IPO | 1 | Reuters | ||
| Fr | India's Reliance Jio eyeing massive IPO in 2026: report | 6 | iNVEZZ.com | ||
| Fr | Nvidia partner Lambda aims to raise at least $350M ahead of IPO this year: report | 17 | Seeking Alpha | ||
| Fr | Tech and finance-focused SPAC Lafayette Digital Acquisition I prices $250 million IPO | 1 | Renaissance Capital | ||
| Fr | Track this: Strava is laying the groundwork for an IPO | 4 | Seeking Alpha | ||
| Fr | Big update On Reliance Jio IPO Plans, Company May Sell 2.5% Stake In India's Largest-Ever Listing | 6 | The Free Press Journal | ||
| Fr | Phase 1 solid tumor biotech Aktis Oncology prices IPO at $18, the high end of the range | 2 | Renaissance Capital | ||
| Fr | Lambda in talks to raise $350m in pre-IPO funding - report | 1 | DatacenterDynamics |
1 2 3 4 5 Weiter >>
Alles anzeigen: Meistgelesene News (24 Stunden)
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .